CIK 0001595248 · Non-accelerated filer<br>Smaller reporting company
Genprex, Inc.
Sign in to watch- Ticker
- GNPX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 900772347
- Phone
- 512-537-7997
- Business address
- 3300 BEE CAVE ROAD SUITE 650-227, AUSTIN, TX, 78746
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-04 | Berger Mark Stanley Chief Medical Officer | Grant or award · Stock Option (right to buy) | +98,750 | 98,750 | ||
| 2022-02-04 | Kumar Hermant Chief Mfgr & Tech Officer | Grant or award · Stock Option (right to buy) | +54,312 | 54,312 | ||
| 2021-09-27 | Kumar Hermant Chief Mfgr & Tech Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2021-09-27 | Berger Mark Stanley Chief Medical Officer | Grant or award · Stock Option (right to buy) | +550,000 | 550,000 | ||
| 2021-06-24 | Wilson William R Jr. Director | Grant or award · Stock Option (right to buy) | +32,376 | 32,376 | ||
| 2021-06-24 | Moreno Toscano Jose Antonio Director | Grant or award · Stock Option (right to buy) | +32,376 | 32,376 | ||
| 2021-06-24 | LONGNECKER BRENT M Director | Grant or award · Stock Option (right to buy) | +32,376 | 32,376 | ||
| 2021-04-05 | LONGNECKER BRENT M Director | Purchase | +15,000 | $4.15 | $62K | 15,000 |
| 2021-03-19 | Confer Ryan M. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +235,000 | 235,000 | ||
| 2021-03-19 | VACZY CATHERINE M EVP GC Chief Strategy Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2021-03-19 | Varner John Rodney President & CEO | Grant or award · Stock Option (right to buy) | +460,000 | 460,000 | ||
| 2021-03-19 | Redman Michael Thomas EVP & Chief Operating Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2020-08-21 | Varner John Rodney President & CEO | Grant or award · Stock Option (right to buy) | +530,000 | 530,000 | ||
| 2020-08-21 | Confer Ryan M. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +270,000 | 270,000 | ||
| 2020-07-24 | Moreno Toscano Jose Antonio Director | Grant or award · Stock Option (right to buy) | +42,068 | 42,068 | ||
| 2020-07-24 | LONGNECKER BRENT M Director | Grant or award · Stock Option (right to buy) | +42,068 | 42,068 | ||
| 2020-07-24 | Wilson William R Jr. Director | Grant or award · Stock Option (right to buy) | +42,068 | 42,068 | ||
| 2019-12-30 | Friedman David E. Director | Grant or award · Stock Option (Right to Buy) | +68,376 | 68,376 | ||
| 2019-12-30 | Pearson Robert W. Director | Grant or award · Stock Option (Right to Buy) | +68,376 | 68,376 | ||
| 2019-12-30 | Friedman David E. Director | Grant or award · Stock Option (Right to Buy) | +68,376 | 68,376 |
Page 3 of 5 · 88 trades